+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 22Years - 85Years
All Genders
ID05836987

REACT-AF Study Comparing Smart Watch-Guided Versus Continuous Anticoagulation in Adults with Atrial Fibrillation

Led by Johns Hopkins University · Updated on 2026-11-03

5350

Participants Needed

93

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a new way to manage anticoagulation therapy in adults aged 22 to 85 with a history of paroxysmal or persistent atrial fibrillation AF who have a low-to-moderate risk of stroke. This Phase 3 trial compares the standard continuous use of direct oral anticoagulants DOACs with a time-limited DOAC treatment guided by an AF-sensing smart watch. The goal is to see if the smart watch method is as effective as continuous treatment in preventing stroke, systemic embolism, and death. Participants are randomly assigned to one of two groups. One group uses a smart watch device that detects AF episodes and takes DOACs for 30 days following a detected AF event lasting over one hour. The other group continues their usual continuous DOAC therapy as prescribed by their doctor. The trial involves up to 5350 participants at up to 100 sites and is expected to last up to 60 months. The smart watch continuously monitors heart rhythm and alerts both the wearer and study center of AF episodes. Throughout the study, participants will use a mobile app linked to their Apple watch for monitoring and follow-up activities. Researchers will regularly assess outcomes including stroke, embolism, mortality, and major bleeding events over 60 months. Participants will be monitored using clinical evaluations, device data, and follow-ups to assess the safety and effectiveness of the two anticoagulation strategies.

CONDITIONS

Brief Title

The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

Research Team

S

Shea Smith

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here